Our Blog

12 Oct

Mesoblast join with Tasly for China deal

By Finance News

12 Oct 2018 – Regenerative medicine comapny Mesoblast (ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic partnership in China for Mesoblast’s product candidates for heart failure.


Source: Finance News Network

Share this post

Related Posts

01 Nov

Wall St glad to say goodbye to October: The ASX poised to open higher

01 Nov 2018 - Australian shares are poised to open higher. Wall St saw... read more

18 Dec

Kogan to launch pet insurance

18 Dec 2017 - Online department store Kogan (ASX:KGN) announces it will launch a... read more

18 Jul

Nasdaq gains for 7th day: ASX tipped for flat start

18 Jul 2017 - Nasdaq gains for 7th day: ASX tipped for flat start.... read more

11 Sep

Pengana Capital working to launch an ASX listed investment trust

11 Sep 2018 - Pengana Capital (ASX:PCG) has announced that it's working on plans... read more

13 Apr

Scout named best DIY home security of 2018

13 Apr 2018 - Home security provider Scout (ASX:SCT) has been named best DIY... read more

13 Nov

Altura Mining announces green light for lithium expansion

13 Nov 2017 - Altura Mining Limited (ASX:AJM) annouces a scoping study has confirmed... read more

20 Oct

Eagle Health opens Australian office

20 Oct 2017 - Eagle Health (ASX:EHH) opens an Australian office in Melbourne. read more

27 Aug

Rural Funds Group looking to buy two QLD properties

27 Aug 2018 - Rural Funds Management as a manager for the Rural Funds... read more

24 May

Orocobre see Lithium increase in Cauchari

24 May 2018 - Orocobre (ASX:ORE) has updated resource estimate for the Company’s Cauchari... read more

01 Feb

Mineral Resources’ total production increases quarter-on-quarter

01 Feb 2018 - Mining company Mineral Resources (ASX:MIN) reports it has produced more... read more